SCHEMBL2370145

SCHEMBL2370145

Cc1ccc(S(=O)(=O)Nc2ncc(C(=O)O)s2)cc1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.53
PFKFB4 Q16877 1/20 0.52
KMT2A Q03164 3/20 0.50
GAA P10253 3/20 0.50
MEN1 O00255 2/20 0.50
FBP1 P09467 1/20 0.50
SMN1; SMN2 Q16637 3/20 0.49
KMO O15229 1/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
POLB P06746 1/20 0.48
APEX1 P27695 1/20 0.48
RECQL P46063 1/20 0.48
CASP6 P55212 1/20 0.48
CTDSP1 Q9GZU7 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
RAB9A P51151 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2371407 0.89 MEN1 (0.54) ALDH1A1KMT2AGAAMEN1FBP1
SCHEMBL15342920 0.78 CA1 (0.52) ALDH1A1KMT2AGAAMEN1FBP1
SCHEMBL5323412 0.77 HCAR2 (0.50) ALDH1A1PFKFB4SMN1; SMN2RAB9A
SCHEMBL11893065 0.76 CA1 (0.60) ALDH1A1KMT2AGAAMEN1SMN1; SMN2
SCHEMBL4200929 0.75 ALDH1A1 (0.80) ALDH1A1KMT2AGAAMEN1SMN1; SMN2
SCHEMBL3251168 0.75 MAPT (0.51) KMT2AGAAMEN1KMORECQL
SCHEMBL3256497 0.74 AKT1 (0.48) ALDH1A1
SCHEMBL4256153 0.73 RAB9A (0.65) ALDH1A1PFKFB4SMN1; SMN2RAB9A
SCHEMBL3154592 0.72 CA1 (0.55) KMT2AGAAMEN1SMN1; SMN2CA1
SCHEMBL14921838 0.72 ALDH1A1 (0.54) ALDH1A1KMT2AGAAMEN1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130281708-A1 Process for the Production of 2-Amino-5-Fluorothiazole TAKEDA CALIFORNIA, INC. (US) 2013-10-24 US disclosed
US-20130281708-A1 Process for the Production of 2-Amino-5-Fluorothiazole TAKEDA CALIFORNIA, INC. (US) 2013-10-24 US disclosed
EP-2547667-A1 PROCESS FOR THE PRODUCTION OF 2-AMINO-5-FLUOROTHIAZOLE Takeda California, Inc. (US) 2013-01-23 EP disclosed
WO-2011115758-A1 PROCESS FOR THE PRODUCTION OF 2-AMINO-5-FLUOROTHIAZOLE TAKEDA SAN DIEGO, INC. (US) 2011-09-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130281708-A1 Process for the Production of 2-Amino-5-Fluorothiazole GFPT1, PFAS, PFKFB4 ALDH1A1 1653/4885PFKFB4 3/4885KMT2A 1405/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.